Excerpted from an extensive multi-market NFTRH update (including global stocks, commodities and precious metals) yesterday morning: Volatility. It is what we expected and it is what we have with Tuesday’s…
"Turnaround Tuesday"... isn't that what they call it? Well, it turned around for several things not called precious metals or China. I did a little buying today of strategic semiconductor…
Okay, so you tell me. Is speculative leadership alive and well in this market? Beuller? We noted in the last NFTRH edition that market sentiment had become positive on a…
In Q4 2014 Europe was hated as an investment destination, what with pervasive deflationary pressures and little more than Draghi's jawbone supporting the idea of a coming QE and a…
The 'apples to apples' chart of unhedged Spain vs. unhedged Deutchland (iShares) continues to sport an interesting pattern that implies the speculative impulse is still alive and well in Europe…
For the same reason I was forced to take profit on Semiconductor company LSCC, I have done the same on gold mine developer AKG. As with the LSCC media buzz,…
Putting on our conventional analysis hats (admittedly, not a hat I wear all too often) we see that the S&P 500 has happily continued higher despite a moderation in corporate…
Over at Biiwii on Monday we noted that a momentum leader to the US stock market - the Biotech sector - was abdicating leadership in favor of the momo driven…
A sleek and flowing 25 pages, NFTRH 340 was emailed to subscribers this morning. It continues a theme of quieting down the theory and focusing on what is happening. We…
I currently own 3 components of the venerable Dow 30 index, so today is fine. But the markets were driven down on China hype on Friday and up on same…
China, in a few pictures (courtesy of TradingEconomics.com): China GDP Annual Growth (through 2014)... China GDP Annual Growth trend projection... China Producer Prices... China Interest Rate... China Loan Growth.. China…
We noted in NFTRH 337 that the EM's were attempting to break through resistance. While this is just short-term stuff (longer-term charts remain neutral at best) the first 3 days…
Here is the S&P 500's closing price, target price and analyst ratings from FactSet... Nothing new or unusual here. A bunch of constructive to bullish analysts and a very few…
Biotech, an important momentum leader to the stock market, is going to need to think about finding support soon lest this become something more than routine. IBB has already made…